Katy Lynn Haddon, APRN, NPC

Katy Haddon practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Katy Haddon's NPI, 1497212807, was assigned on February 22, 2019. Katy Haddon holds Florida license APRN11001022.

Katy Haddon's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Katy Haddon's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Katy Haddon to 2 more group practices and clinics and 1 medical group, each named with a free account. Katy Haddon's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Katy Haddon practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Katy Haddon's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Katy Haddon is licensed in Florida.

Dmand AI lists high cholesterol, pneumonia, rash, tobacco use, upper respiratory infection (URI), UTI and vitamin b deficiency among the conditions Katy Haddon treats.

CMS data shows 601 Medicare services from Katy Haddon across 4 procedure codes in 2024, for 227 Medicare patients. Medicare paid $39,737 for them. Every service was in an office.

CMS counts 227 Medicare patients who saw Katy Haddon in 2024. The largest group is 75 to 84, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Katy Haddon's median patient age at 69, with 68% women.

In 2024, Katy Haddon wrote 821 Medicare Part D claims for 217 patients. 82% of them were for generic drugs. CMS names the drug for 621 of them, across 24 drugs with 11 or more claims each, at $1,287,630 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Katy Haddon for performance year 2024, reported through an alternative payment model (APM). Katy Haddon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Katy Haddon as offering telehealth.

CMS Open Payments shows 19 general payments to Katy Haddon from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 44% of the total. Pfizer Inc. paid the most, $1,190.